Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 110.22 USD 1.68% Market Closed
Market Cap: 21.9B USD
Have any thoughts about
Zimmer Biomet Holdings Inc?
Write Note

Zimmer Biomet Holdings Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zimmer Biomet Holdings Inc
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Zimmer Biomet Holdings Inc
NYSE:ZBH
Cost of Revenue
-$2.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-5%
Becton Dickinson and Co
NYSE:BDX
Cost of Revenue
-$11B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Boston Scientific Corp
NYSE:BSX
Cost of Revenue
-$4.9B
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Stryker Corp
NYSE:SYK
Cost of Revenue
-$7.9B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Cost of Revenue
-$18.3B
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cost of Revenue
-$2.6B
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
No Stocks Found

Zimmer Biomet Holdings Inc
Glance View

Market Cap
22B USD
Industry
Health Care

Zimmer Biomet Holdings Inc. is a leading global medical device company renowned for its innovative solutions in the musculoskeletal health sector. Founded in 1927 and headquartered in Warsaw, Indiana, the company specializes in orthopedic implants, including those used in joint reconstruction and spinal surgery, as well as dental and neuromuscular devices. With a commitment to enhancing the quality of life for patients worldwide, Zimmer Biomet leverages cutting-edge technology and extensive research to develop products that cater to an aging population and a growing demand for minimally invasive surgical options. As the healthcare landscape evolves, Zimmer Biomet’s adaptable business strategy and focus on strategic partnerships position it favorably to capture new market opportunities and drive future growth. For investors, Zimmer Biomet represents a compelling choice within the healthcare sector due to its strong market presence and consistent revenue generation. The company operates in a resilient industry characterized by ongoing technological advancements and a steady demand for orthopedic procedures driven by demographic trends. Zimmer Biomet has strategically streamlined its operations, enhancing operational efficiencies and reducing costs, which are promising signs of financial health. With a robust pipeline of innovative products and a focus on expanding its global footprint, Zimmer Biomet is well-equipped to navigate the complexities of the healthcare market and deliver sustainable value to its shareholders over the long term.

ZBH Intrinsic Value
153.21 USD
Undervaluation 28%
Intrinsic Value
Price

See Also

What is Zimmer Biomet Holdings Inc's Cost of Revenue?
Cost of Revenue
-2.1B USD

Based on the financial report for Sep 30, 2024, Zimmer Biomet Holdings Inc's Cost of Revenue amounts to -2.1B USD.

What is Zimmer Biomet Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-5%

Over the last year, the Cost of Revenue growth was -4%.

Back to Top